Hodgkin Disease Clinical Trials

104 clinical trials for Hodgkin Disease across international registries, including 5 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Biospecimen Procurement for Center for Immuno-Oncology Immunotherapy Protocols — RECRUITING
• Tissue Collection for Studies of Lymph Cancer — RECRUITING
• Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic Malignancies — RECRUITING · PHASE1
• PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma — RECRUITING · PHASE2
• Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines — RECRUITING
• Clinical, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Hematologic Cancer — ACTIVE_NOT_RECRUITING
• Study to Evaluate the Safety and Efficacy of a Combination of Favezelimab (MK-4280) and Pembrolizumab (MK-3475) in Participants With Hematologic Malignancies (MK-4280-003) — TERMINATED · PHASE1
• A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant — ACTIVE_NOT_RECRUITING · PHASE2
• A Safety Study of PF-08046044/SGN-35C in Adults With Advanced Cancers — TERMINATED · PHASE1
• A Safety Study of PF-08046045/SGN-35T in Adults With Advanced Cancers — TERMINATED · PHASE1
• A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma — TERMINATED · PHASE1
• Administration of T Lymphocytes for Prevention of Relapse of Lymphomas — ACTIVE_NOT_RECRUITING · PHASE1
• Administration of TAA-Specific CTLs; Hodgkin or Non-Hodgkin Lymphoma; TACTAL — ACTIVE_NOT_RECRUITING · PHASE1
• Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among Survivors — COMPLETED · NA
• Most Closely Matched 3rd Party Rapidly Generated LMP, BARF1 And EBNA1 Specific CTL, EBV-Positive Lymphoma (MABEL) — ACTIVE_NOT_RECRUITING · PHASE1
• Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood Disorders — COMPLETED · NA
• Feasibility and Agreement of Remote Evaluation of Resting Heart Rate and Heart Rate Variability in Survivors of Hodgkin Lymphoma Treated With Chest Radiation (PILOT STUDY-SURVIVOR) — COMPLETED
• A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma — ACTIVE_NOT_RECRUITING · PHASE1
• Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma — ACTIVE_NOT_RECRUITING · PHASE3
• A Post-treatment Program to Identify and Manage Complications Related to Oncology or Hematology Treatments in Cancer Survivors. — ACTIVE_NOT_RECRUITING · NA
• Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment. — COMPLETED
• Study of Itacitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation — COMPLETED · PHASE1
• A Study of Nivolumab Plus Brentuximab Vedotin in Patients Between 5 and 30 Years Old, With Hodgkin's Lymphoma (cHL), Relapsed or Refractory From First Line Treatment — COMPLETED · PHASE2
• Cytotoxic T Cells to Treat Relapsed EBV-positive Lymphoma — COMPLETED · PHASE1
• Imaging of Chemotherapy-induced Morphological and Functional Lung Changes in Childhood ALL and HD — COMPLETED · NA
• Atorvaststin and Cardiotoxicity in Acute Myloid Leukemia — NOT_YET_RECRUITING · PHASE1
• A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin — COMPLETED
• A Study to Describe Treatment Patterns and Disease Control in Participants With cHL and sALCL in Routine Clinical Practice in the Russian Federation — COMPLETED
• Cardiac Rehabilitation for Patients Receiving Radiation Therapy for Thoracic Cancers — TERMINATED · NA
• A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) — COMPLETED · PHASE2
• Hodgkin's Disease and Chemotherapy Before 40 Years — NOT_YET_RECRUITING · NA
• Occupational Status and Hematological Disease — COMPLETED
• Chemotherapy With or Without Radiation, Low and Intermediate Risk Hodgkins Lymphoma, TXCH-HD-12A — COMPLETED · PHASE2
• Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) — COMPLETED · PHASE2
• Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies — COMPLETED · PHASE2
• Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's Lymphoma — COMPLETED
• Blood Samples to Identify Biomarkers in Haploidentical Graft Recipients — COMPLETED
• Safety Study of SEA-CD40 in Cancer Patients — TERMINATED · PHASE1
• Effects of Prebiotics on Gut Microbiome in Patients Undergoing HSCT — COMPLETED · NA
• Fitness Assessment in Young Adults Recovered From Lymphoma — COMPLETED · NA
• Brazilian Prospective Hodgkin Lymphoma Registry — OTHER
• Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICE — COMPLETED · PHASE1
• Yttrium-90-labeled Daclizumab With Chemotherapy and Stem Cell Transplant for Hodgkin's Lymphoma — TERMINATED · PHASE1
• Carfilzomib and TGR-1202 in Treatment of R/R Lymphoma — TERMINATED · PHASE1
• Safety and PK/PD of TG-0054 in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients — COMPLETED · PHASE2
• PD and Safety of TG-0054 Combined With G-CSF in Multiple Myeloma, Non-Hodgkin Lymphoma and Hodgkin Disease Patients — COMPLETED · PHASE2
• Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins Lymphoma — COMPLETED · PHASE1
• Brentuximab Vedotin in Chinese Participants With Relapsed/Refractory CD30-Positive Hodgkin Lymphoma (HL) or Systemic Anaplastic Large Cell Lymphoma (sALCL) — COMPLETED · PHASE2
• Acceleration of Platelet Recovery Following Autologous Peripheral Blood Stem Cell Transplant (PBSC) in Hodgkin, Non-Hodgkin Lymphoma or Multiple Myeloma Patients — TERMINATED · PHASE2
• Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas — COMPLETED · PHASE1

Refine this search